Clinical Studies

Treating Intestinal Infections in Children Using the Deta-AP and Deta-Ritm devices: Paediatric Clinic of Salabat City (Russia)

This health survey was conducted under the supervision of Dr. Giatsenko Archiatroy and Dr. Fakoylinz, both paediatricians. The investigation lasted six months in total from October 2009 to March 2010. There was a total sample of 48 children, aged from 5 to 14 years old who were diagnosed with parasitic infestations of ascariasis and giardiasis, both common intestinal infections. The children were divided into three groups: Treated only with prescription medication Treated only with the Deta-AP and Deta-Ritm devices Treated with prescription medications, as well as the Deta-AP and Deta-Ritm devices. In the first group when only prescribed medication was used to eliminate these intestinal parasites, there was a 48% cure rate. In the second group where only the Deta-AP and Deta-Ritm devices were used, there was an 86% cure rate, while when both the devices and medications were combined there was a 94% cure rate. The main disadvantages of using medications is that they have side effects that vary from patient to patient. The Deta-AP and Deta-Ritm devices however did not have any such side effects and were completey safe and easy to use with these children.

Intestinal Infections in Children

The Use of the DETA devices on school children in the Children’s Anti-tuberculosis Health Resort of the city of Ufa, Russia Doctor G.T. Khalikova

The Use of the DETA devices on school children in the Children’s Anti-tuberculosis Health Resort of the city of Ufa, Russia Doctor G.T. Khalikova The aim of the tests was to evaluate the efficiency and safety of DETA-AP and DETA-RITM devices in a Children’s Anti-Tuberculosis Health Resort. One DETA-AP device and one DETA-RITM device were used during all the tests. Patients medically diagnosed using clinical testing with the following diseases were treated with DETA-AP device: - Ascariasis; - Enterobiasis; - Lambliosis. The “Antihelmetic” program was used once per week for a period of one month. At the same time the children also received antihelminthic herbs from the root of sweet flag and wormwood tinctures. Before running the “antihelmetic” programs, the Deta AP “Drainage” programme was run for 17 minutes. Depending on the type of helminth the following Deta AP programmes were used: - Seatworm; - Ascarid; - General parasites. All programmes were run for 35 minutes. Lamblia programme was carried out twice during one month, run time of the program was 45 minutes. Immediately after each “antihelmetic” programme, the “drainage therapy” programme was run to help eliminate toxins related to the parasite die-off – run-time 17 minutes. If after running the anti-parasite programme, there were mild gastrointestinal tract symptoms, then the Deta Ritm programme for “gastrointestinal tract regulation” was used for 40 minutes. The DETA-RITM was used mainly with children having gastroduodenitis, biliary dyskinesia and cholecystitis. For all these cases, the “Active Defense” programme was used for 40 minutes initially. The child would then take a break for an hour, and then the “gastrointestinal tract regulation” programme was used for 40 minutes. The child would then take another break for an hour, then the “Deep Cleaning” programme was used for 40 minutes. All children were required to drink plenty of water to help the flushing of toxins – 30 ml. water to each kilo of body weight. Here are examples of various programmes ran on the Deta AP for various parasites: Set of programs to treat Ascariasis Drainage therapy – 17 minutes. Ascarids – 35 minutes. Repeat Drainage therapy – 17 minutes. Set of programs to treat Lambliosis Drainage therapy – 17 minutes. Lamblias – 45 minutes. Repeat Drainage therapy – 17 minutes. Set of programs to treat enterobiasis Drainage therapy – 17 minutes. Seatworms – 35 minutes. Repeat Drainage therapy – 45 minutes. These treatment complexes for Ascariasis, Lambliosis and Enterobiasis was carried out one or two times per week for one month. Set of programs to treat Gastroduodenitis and biliary Dyskinesia Active Defense mode 1-hour pause Gastrointestinal tract regulation 1-hour pause Deep cleaning 40 minutes. This treatment complex was applied once a day for 30 days. Set of programs to treat neurosis-like conditions (hyperactivity and excitability) of children Active Defense Blood circulation Gastrointestinal tract regulation Deep cleaning This treatment complex was applied once per day for 20 consecutive days. The Deta devices were used with children up to 4 years old – most of the children wore the devices over their clothes in their breast pocket.

Children’s Anti-tuberculosis Health Resort

Testing the Efficacy of the DETA-AP devices as part of treating patients having Pulmonary Tuberculosis (TB)

The aim of this clinical pilot study was to determine the efficacy of the Deta AP bioresonance devices with patients that had been clinically diagnosed with Pulmonary TB, including multiple drug-resistant TB. The trials were conducted at the State Health Care Institution of the Yaroslavl Region Regional Clinical Hospital for Tuberculosis, Russia. Twenty five patients having tuberculosis were tested, among them there were 11 women, 14 men and 9 of these patients had multiple drug-resistant tuberculosis. The age of the men was from 24 to 56 years old, the women from 24 to 58 years old. The Deta AP therapy programme “Tuberculosis” was run for the prescribed period of time, once per week for 30 days. Criteria for assessing the efficiency of treatment were clinical, radiological and bacteriological examinations. Radiological improvements were observed in 18 cases (72%); a further 6 cases (24%) had no change and only 1 case got worse (4%). According to the bacteriological examination, a complete eradication of the TB bacterium was seen in 12 cases (48%), BK (-) in 8 cases before and after the examination, with 4 patients that were still positive. One patient had to terminate treatment after 4 sessions, as drug liver disease and hepato-renal syndrome developed. It should be noted that all programmes of the devices are well-tolerated, and there were no adverse reactions to the treatment. Conclusions 1. DETA-AP treatment is safe for TB infections. 2. The applied treatment protocols for TB should be further developed – increasing exposure time, multiple sessions, extending the duration of treatment from one month to 2-4 months.

Pulmonary Tuberculosis (TB)

Pediatric Clinic No 2, Oyfa City (Russia) using the Deta-Ritm and Deta-AP in the treatment of children and adolescents with osteroporosis and osteopenia, as well as digestive problems

This survey was conducted under the supervision of the Professor of the Department of Pediatrics of the State Medical University of the Republic of Bashkortostan, Southeast Ntroyzinin. 63 children were monitored, aged 12 to 15 years (43 girls and 20 boys). All these children underwent extensive testing and clinically diagnosed. The children were divided into two groups: Treated for calcium metabolism disorders using the drug Calcemin Treated for calcium metabolism disorders using only the Deta-Ritm and Deta-AP devices; for ten consecutive days. Effectiveness of Treatments (%) Health Problems Deta-Ritm & AP Devices only Drug Calcemin Pain, appetite, indigestion 93,2% 82.6% Inflammation, action speed 87.7% 72,1% Statistical Testing (T-Test) 91.6% 78.3% The results showed that the group of children treated only with the Deta-AP and Ritm devices had a statistically significant difference – more effective – than the group that was treated only with the prescription drug Calcemin. This was for the two major health issues of digestive problems and inflammation with pain.

Pediatric Clinic No.2

Pediatric Clinic No. 1, Borones (Russia) – effectiveness of the Deta-AP and Deta-Ritm devices on 341 Children with Various Diseases

The survey was conducted from March 2003 to April 2005 under the supervision of assistant consultant, Dr. Gkolopkoba and T.B. pediatrician Dr. Nteineka. 341 patients were treated with the Deta devices, aged from 7 to 15 years. These 341 children were divided into 5 groups, as follows: Problems with vision (myopia, presbypoia and astigmatism) – 166 patients. Problems with gastrointestinal system (chronic inflammation of the duodenum, colitis, bile dyskinesia) – 18 patients. Autonomic Nervous System problems – 130 patients. Musculoskeletal problems (scoliosis and osteochondrosis of the vertebral column) – 18 patients. Respiratory problems (bronchial asthma, bronchitis) – 9 patients. GROUPS HEALTH PROBLEMS PERCENTAGE IMPROVEMENT Vision problems 66% Gastrointestinal 98.7% Autonomic Nervous System 97.6% Musculoskeletal 46% Respiratory 94.6% The improvements that many of these children had were really quite remarkable, given that the only treatment they received was with the Deta-AP and the Deta-Ritm – no other medication was used.

Pediatric Clinic No.1